Stem Cells and COVID-19

Herausgeber: Sharma, Chandra P.; Thankam, Finosh G.; Agrawal, Devendra K.

• Broschiertes Buch

Produktbeschreibung

Stem Cells and COVID-19 presents up-to-date knowledge on the effect of hematopoietic and mesenchymal stem cells to combat SARS-CoV-2 infection in its diagnosis, treatment and prevention. In addition, the book critically discusses challenges, highlighting outstanding questions and future perspectives. Written by global experts in the field for both pre-clinical and clinical practitioners, this comprehensive book delves into how stem cells have a strong potential in developing better diagnostic, treatment and preventive strategies in SARS-CoV-2 infection. Both hematopoietic and mesenchymal stem cells are critical to better understand the response of immune system to coronavirus infection in both healthy and co-morbid conditions in the development of effective vaccines and immunotherapies.

Produktdetails

• Verlag: Elsevier Science & Technology
• Seitenzahl: 248
• Erscheinungstermin: 22. April 2022
• Englisch
• Abmessung: 189mm x 232mm x 21mm
• Gewicht: 530g
• ISBN-13: 9780323899727
• ISBN-10: 0323899722
• Artikelnr.: 62753974

Inhaltsangabe

1. Introduction
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target
organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets
for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating
COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells
- potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling
in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational
possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models -
Validation, Management & Strategies
12. Therapy: present & future clinical perspective